BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10713117)

  • 21. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells.
    Fayad R; Brand MI; Stone D; Keshavarzian A; Qiao L
    Eur J Immunol; 2006 Aug; 36(8):2215-22. PubMed ID: 16856205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
    Dicker F; Kater AP; Fukuda T; Kipps TJ
    Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.
    Wendling U; Walczak H; Dörr J; Jaboci C; Weller M; Krammer PH; Zipp F
    Cell Death Differ; 2000 Jul; 7(7):637-44. PubMed ID: 10889508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
    Thomas LR; Johnson RL; Reed JC; Thorburn A
    J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceleration of human neutrophil apoptosis by TRAIL.
    Renshaw SA; Parmar JS; Singleton V; Rowe SJ; Dockrell DH; Dower SK; Bingle CD; Chilvers ER; Whyte MK
    J Immunol; 2003 Jan; 170(2):1027-33. PubMed ID: 12517970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic epithelial cells induce Fas-independent activation apoptosis of thymocytes.
    Sharova NI; Dzutsev AK; Litvina MM; Pleskovskaya GN; Kharchenko TY; Yarilin AA
    Immunol Lett; 2001 Oct; 78(3):201-7. PubMed ID: 11578696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas/Fas ligand signaling during gestational T cell development.
    Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
    J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death.
    Bergeron S; Beauchemin M; Bertrand R
    Mol Cancer Ther; 2004 Dec; 3(12):1659-69. PubMed ID: 15634660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Support for an infection-induced apoptotic pathway in human fetal membranes.
    Fortunato SJ; Menon R; Lombardi SJ
    Am J Obstet Gynecol; 2001 Jun; 184(7):1392-7; discussion 1397-8. PubMed ID: 11408858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.